Darenzepine |
| Catalog No.GC31136 |
La darenzépine est un inhibiteur des récepteurs muscariniques extrait du brevet US 20170095465 A1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 84629-61-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders[1].
[1]. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.
Average Rating: 5 (Based on Reviews and 28 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *